J Valentine1, T Saladyanant2, K Ramsey2, J Blake2, T Morelli1, J Southerland3, E B Quinlivan4, C Phillips2, Jae Nelson5,4, K DeParis5,4, J Webster-Cyriaque5,6,4. 1. Department of Periodontology, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 2. Department of Dental Research, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3. MeHarry School of Dentistry, Medical College, Nashville, TN, USA. 4. Institute of Global Health and Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 5. Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 6. Department of Dental Ecology, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract
OBJECTIVE: The aim of this study was to determine active periodontal disease status in HIV and to determine the impact of periodontal disease resolution on HIV status. METHODS: In this longitudinal cohort study, 73 HIV-positive subjects received comprehensive dental care. AAP, CDC/AAP, and BGI case definitions determined periodontal classification. Likelihood and frequency of moderate/severe periodontal disease were assessed based on demographic variables. The influence of periodontal intervention was assessed at baseline, 12, and 24 months. IL-6 was measured in a subset of subjects. RESULTS: Of the periodontal classifications, BGI demonstrated the highest percentage category improvement with the intervention (>50%). Moderate/severe periodontitis was positively associated with HIV regardless of race, smoking status, gender, income level, and age, and was associated with increased IL-6. At baseline, the majority of subjects had severe periodontal disease regardless of ART status. Subjects with suppressed viral load at baseline demonstrated a significant improvement in BGI classification (P = 0.026), increased CD4 counts (P = 0.027), and decreased IL-6 levels (P = 0.03). CONCLUSIONS: Periodontal inflammation was prevalent regardless of ART status. In virologically suppressed subjects, the intervention decreased periodontitis with a concomitant IL-6 decrease and CD4 increase. These findings suggest a relationship between periodontal inflammation, oral microbial translocation, and HIV status.
OBJECTIVE: The aim of this study was to determine active periodontal disease status in HIV and to determine the impact of periodontal disease resolution on HIV status. METHODS: In this longitudinal cohort study, 73 HIV-positive subjects received comprehensive dental care. AAP, CDC/AAP, and BGI case definitions determined periodontal classification. Likelihood and frequency of moderate/severe periodontal disease were assessed based on demographic variables. The influence of periodontal intervention was assessed at baseline, 12, and 24 months. IL-6 was measured in a subset of subjects. RESULTS: Of the periodontal classifications, BGI demonstrated the highest percentage category improvement with the intervention (>50%). Moderate/severe periodontitis was positively associated with HIV regardless of race, smoking status, gender, income level, and age, and was associated with increased IL-6. At baseline, the majority of subjects had severe periodontal disease regardless of ART status. Subjects with suppressed viral load at baseline demonstrated a significant improvement in BGI classification (P = 0.026), increased CD4 counts (P = 0.027), and decreased IL-6 levels (P = 0.03). CONCLUSIONS: Periodontal inflammation was prevalent regardless of ART status. In virologically suppressed subjects, the intervention decreased periodontitis with a concomitant IL-6 decrease and CD4 increase. These findings suggest a relationship between periodontal inflammation, oral microbial translocation, and HIV status.
Authors: Paul I Eke; Bruce A Dye; Liang Wei; Gary D Slade; Gina O Thornton-Evans; Wenche S Borgnakke; George W Taylor; Roy C Page; James D Beck; Robert J Genco Journal: J Periodontol Date: 2015-02-17 Impact factor: 6.993
Authors: Jorge O Alarcón; Laura Freimanis-Hance; Margot Krauss; Mary F Reyes; Claudete Aparecida Araújo Cardoso; Marisa M Mussi-Pinhata; Edmundo Cardoso; Rohan Hazra Journal: AIDS Res Hum Retroviruses Date: 2011-09-19 Impact factor: 2.205
Authors: Rachel M Presti; Scott A Handley; Lindsay Droit; Mahmoud Ghannoum; Mark Jacobson; Caroline H Shiboski; Jennifer Webster-Cyriaque; Todd Brown; Michael T Yin; Edgar T Overton Journal: AIDS Date: 2018-06-19 Impact factor: 4.177
Authors: Adaora A Adimora; Elizabeth Topper Golub; Seble G Kassaye; Aadia Rana; Daniel Westreich; Anandi N Sheth; Jennifer Webster Cyriaque; Carrigan Parish; Deborah Konkle-Parker; Deborah L Jones; Mirjam-Colette Kempf; Igho Ofotokun; Ruth M Kanthula; Jessica Donohue; Patricia Raccamarich; Tina Tisdale; Catalina Ramirez; Lari Warren-Jeanpiere; Phyllis C Tien; Maria L Alcaide Journal: JMIR Res Protoc Date: 2021-12-20
Authors: Marianna S Wetherill; Casey Bakhsh; Lacey Caywood; Mary B Williams; Micah L Hartwell; Denna L Wheeler; Randolph D Hubach; T Kent Teague; Gerwald Köhler; James R Hebert; Sheri D Weiser Journal: Front Clin Diabetes Healthc Date: 2022-08-16
Authors: Carrigan L Parish; Daniel J Feaster; Margaret R Pereyra; Maria L Alcaide; Kathleen M Weber; Mardge H Cohen; Susanna Levin; Deborah Gustafson; Daniel Merenstein; Bradley E Aouizerat; Jessica Donohue; Jennifer Webster-Cyriaque; Gina Wingood; Mirjam-Colette Kempf; Lisa R Metsch Journal: J Public Health Dent Date: 2020-10-13 Impact factor: 1.821